T0	Participants 120 155	breathlessness in advanced disease.
T1	Participants 234 242	patients
T2	Participants 394 457	breathless patients with advanced disease (regardless of cause)
T3	Participants 1097 1258	patients with malignant disease (intervention delivered over two weeks) and one for patients with non-malignant disease (intervention delivered over four weeks).
T4	Participants 1328 1434	patients with malignant conditions (four week protocol) and one for patients with non-malignant conditions